{"transactions":[{"id":692270,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2026-08-10T20:15:09.000Z","date":"2026-08-06","kind":"grant","planned":false,"acquired":true,"shares":11699,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported securities represent restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date."}],"balance_after":15177,"source":{"system":"sec-edgar","filing":"0001104659-26-093378","document":"tm2622592-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926093378/tm2622592-1_4seq1.xml","form_type":"4"}},{"id":694542,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2026-08-07T00:10:19.000Z","date":"2026-08-04","kind":"other","planned":false,"acquired":false,"shares":486,"price":36.599,"value":17787.114,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units."}],"balance_after":3478,"source":{"system":"sec-edgar","filing":"0001104659-26-092227","document":"tm2622506-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926092227/tm2622506-1_4seq1.xml","form_type":"4"}},{"id":719067,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance Stock Units","published_at":"2026-07-02T20:15:10.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive one share of Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The PSUs shall vest (or be forfeited), in full or in part, on June 30, 2031, subject to achievement of specified stock price performance measured as of, and subject to the Reporting Person's continued employment on, such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The PSUs shall vest (or be forfeited), in full or in part, on June 30, 2031, subject to achievement of specified stock price performance measured as of, and subject to the Reporting Person's continued employment on, such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The PSUs shall vest (or be forfeited), in full or in part, on June 30, 2031, subject to achievement of specified stock price performance measured as of, and subject to the Reporting Person's continued employment on, such date."}],"balance_after":300000,"derivative":{"exercise_date":"2031-06-30","expiration_date":"2031-06-30","underlying":"Class A Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001104659-26-080332","document":"tm2619107-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926080332/tm2619107-1_4seq1.xml","form_type":"4"}},{"id":1062777,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2025-08-19T20:17:14.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":3964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported securities represent restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, subject to the Reporting Person's continued employment through the applicable vesting date."}],"balance_after":3964,"source":{"system":"sec-edgar","filing":"0001104659-25-080266","document":"tm2523826-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465925080266/tm2523826-4_4seq1.xml","form_type":"4"}},{"id":3682785,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2019-01-31T02:07:39.000Z","date":"2019-01-30","kind":"exercise","acquired":false,"shares":2390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":0,"derivative":{"exercise_price":11.83,"exercise_date":"2014-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":2390},"source":{"system":"sec-edgar","filing":"0001144204-19-003872","document":"tv511990_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419003872/tv511990_4.xml","form_type":"4"}},{"id":3682784,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2019-01-31T02:07:39.000Z","date":"2019-01-29","kind":"exercise","acquired":false,"shares":4890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":2390,"derivative":{"exercise_price":11.83,"exercise_date":"2013-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":4890},"source":{"system":"sec-edgar","filing":"0001144204-19-003872","document":"tv511990_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419003872/tv511990_4.xml","form_type":"4"}},{"id":3682783,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2019-01-31T02:07:39.000Z","date":"2019-01-28","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":7280,"derivative":{"exercise_price":11.83,"exercise_date":"2013-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001144204-19-003872","document":"tv511990_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419003872/tv511990_4.xml","form_type":"4"}},{"id":3682782,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-31T02:07:39.000Z","date":"2019-01-30","kind":"sale","acquired":false,"shares":2390,"price":31.15,"value":74448.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.04 to $31.30, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-19-003872","document":"tv511990_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419003872/tv511990_4.xml","form_type":"4"}},{"id":3682781,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-31T02:07:39.000Z","date":"2019-01-30","kind":"exercise","acquired":true,"shares":2390,"price":11.83,"value":28273.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":2390,"source":{"system":"sec-edgar","filing":"0001144204-19-003872","document":"tv511990_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419003872/tv511990_4.xml","form_type":"4"}},{"id":3682780,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-31T02:07:39.000Z","date":"2019-01-29","kind":"sale","acquired":false,"shares":4890,"price":31.32,"value":153154.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.08 to $31.73, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-19-003872","document":"tv511990_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419003872/tv511990_4.xml","form_type":"4"}},{"id":3682779,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-31T02:07:39.000Z","date":"2019-01-29","kind":"exercise","acquired":true,"shares":4890,"price":11.83,"value":57848.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":4890,"source":{"system":"sec-edgar","filing":"0001144204-19-003872","document":"tv511990_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419003872/tv511990_4.xml","form_type":"4"}},{"id":3682778,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-31T02:07:39.000Z","date":"2019-01-28","kind":"sale","acquired":false,"shares":2500,"price":31.55,"value":78875.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.19 to $32.08, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-19-003872","document":"tv511990_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419003872/tv511990_4.xml","form_type":"4"}},{"id":3682777,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-31T02:07:39.000Z","date":"2019-01-28","kind":"exercise","acquired":true,"shares":2500,"price":11.83,"value":29575.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001144204-19-003872","document":"tv511990_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419003872/tv511990_4.xml","form_type":"4"}},{"id":3688309,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2019-01-25T02:04:10.000Z","date":"2019-01-24","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":9780,"derivative":{"exercise_price":11.83,"exercise_date":"2014-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001144204-19-002703","document":"tv511485_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419002703/tv511485_4.xml","form_type":"4"}},{"id":3688308,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2019-01-25T02:04:10.000Z","date":"2019-01-23","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":12280,"derivative":{"exercise_price":11.83,"exercise_date":"2013-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001144204-19-002703","document":"tv511485_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419002703/tv511485_4.xml","form_type":"4"}},{"id":3688307,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2019-01-25T02:04:10.000Z","date":"2019-01-22","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":14780,"derivative":{"exercise_price":11.83,"exercise_date":"2013-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001144204-19-002703","document":"tv511485_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419002703/tv511485_4.xml","form_type":"4"}},{"id":3688306,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-25T02:04:10.000Z","date":"2019-01-24","kind":"sale","acquired":false,"shares":2500,"price":31.78,"value":79450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.60 to $32.10, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-19-002703","document":"tv511485_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419002703/tv511485_4.xml","form_type":"4"}},{"id":3688305,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-25T02:04:10.000Z","date":"2019-01-24","kind":"exercise","acquired":true,"shares":2500,"price":11.83,"value":29575.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001144204-19-002703","document":"tv511485_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419002703/tv511485_4.xml","form_type":"4"}},{"id":3688304,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-25T02:04:10.000Z","date":"2019-01-23","kind":"sale","acquired":false,"shares":590,"price":32.18,"value":18986.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.13 to $32.21, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-19-002703","document":"tv511485_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419002703/tv511485_4.xml","form_type":"4"}},{"id":3688303,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-25T02:04:10.000Z","date":"2019-01-23","kind":"sale","acquired":false,"shares":1910,"price":31.58,"value":60317.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.10 to $32.07, inclusive."}],"balance_after":590,"source":{"system":"sec-edgar","filing":"0001144204-19-002703","document":"tv511485_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419002703/tv511485_4.xml","form_type":"4"}},{"id":3688302,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-25T02:04:10.000Z","date":"2019-01-23","kind":"exercise","acquired":true,"shares":2500,"price":11.83,"value":29575.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001144204-19-002703","document":"tv511485_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419002703/tv511485_4.xml","form_type":"4"}},{"id":3688301,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-25T02:04:10.000Z","date":"2019-01-22","kind":"sale","acquired":false,"shares":2500,"price":31.4,"value":78500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.15 to $31.82, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-19-002703","document":"tv511485_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419002703/tv511485_4.xml","form_type":"4"}},{"id":3688300,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-25T02:04:10.000Z","date":"2019-01-22","kind":"exercise","acquired":true,"shares":2500,"price":11.83,"value":29575.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001144204-19-002703","document":"tv511485_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419002703/tv511485_4.xml","form_type":"4"}},{"id":3692030,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2019-01-19T02:00:15.000Z","date":"2019-01-18","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":17280,"derivative":{"exercise_price":11.83,"exercise_date":"2014-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001144204-19-002146","document":"tv511196_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419002146/tv511196_4.xml","form_type":"4"}},{"id":3692029,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2019-01-19T02:00:15.000Z","date":"2019-01-17","kind":"exercise","acquired":false,"shares":110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":19780,"derivative":{"exercise_price":11.83,"exercise_date":"2014-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":110},"source":{"system":"sec-edgar","filing":"0001144204-19-002146","document":"tv511196_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419002146/tv511196_4.xml","form_type":"4"}},{"id":3692028,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2019-01-19T02:00:15.000Z","date":"2019-01-17","kind":"exercise","acquired":false,"shares":2390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":0,"derivative":{"exercise_price":11.83,"exercise_date":"2013-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":2390},"source":{"system":"sec-edgar","filing":"0001144204-19-002146","document":"tv511196_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419002146/tv511196_4.xml","form_type":"4"}},{"id":3692027,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2019-01-19T02:00:15.000Z","date":"2019-01-16","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":2390,"derivative":{"exercise_price":11.83,"exercise_date":"2013-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001144204-19-002146","document":"tv511196_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419002146/tv511196_4.xml","form_type":"4"}},{"id":3692026,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-19T02:00:15.000Z","date":"2019-01-18","kind":"sale","acquired":false,"shares":2500,"price":32.04,"value":80100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.88 to $32.19, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-19-002146","document":"tv511196_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419002146/tv511196_4.xml","form_type":"4"}},{"id":3692025,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-19T02:00:15.000Z","date":"2019-01-18","kind":"exercise","acquired":true,"shares":2500,"price":11.83,"value":29575.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001144204-19-002146","document":"tv511196_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419002146/tv511196_4.xml","form_type":"4"}},{"id":3692024,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-19T02:00:15.000Z","date":"2019-01-17","kind":"sale","acquired":false,"shares":2500,"price":32.24,"value":80600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.09 to $32.42, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-19-002146","document":"tv511196_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419002146/tv511196_4.xml","form_type":"4"}},{"id":3692023,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-19T02:00:15.000Z","date":"2019-01-17","kind":"exercise","acquired":true,"shares":2500,"price":11.83,"value":29575.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001144204-19-002146","document":"tv511196_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419002146/tv511196_4.xml","form_type":"4"}},{"id":3692022,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-19T02:00:15.000Z","date":"2019-01-16","kind":"sale","acquired":false,"shares":2500,"price":32.4,"value":81000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.13 to $32.51, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-19-002146","document":"tv511196_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419002146/tv511196_4.xml","form_type":"4"}},{"id":3692021,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-19T02:00:15.000Z","date":"2019-01-16","kind":"exercise","acquired":true,"shares":2500,"price":11.83,"value":29575.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001144204-19-002146","document":"tv511196_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419002146/tv511196_4.xml","form_type":"4"}},{"id":3698405,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2019-01-11T02:14:23.000Z","date":"2019-01-09","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":4890,"derivative":{"exercise_price":11.83,"exercise_date":"2013-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001144204-19-001393","document":"tv510834_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419001393/tv510834_4.xml","form_type":"4"}},{"id":3698404,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2019-01-11T02:14:23.000Z","date":"2019-01-08","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":7390,"derivative":{"exercise_price":11.83,"exercise_date":"2013-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001144204-19-001393","document":"tv510834_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419001393/tv510834_4.xml","form_type":"4"}},{"id":3698403,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-11T02:14:23.000Z","date":"2019-01-09","kind":"sale","acquired":false,"shares":2500,"price":32.54,"value":81350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-19-001393","document":"tv510834_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419001393/tv510834_4.xml","form_type":"4"}},{"id":3698402,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-11T02:14:23.000Z","date":"2019-01-09","kind":"exercise","acquired":true,"shares":2500,"price":11.83,"value":29575.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001144204-19-001393","document":"tv510834_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419001393/tv510834_4.xml","form_type":"4"}},{"id":3698401,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-11T02:14:23.000Z","date":"2019-01-08","kind":"sale","acquired":false,"shares":2500,"price":32.31,"value":80775.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-19-001393","document":"tv510834_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419001393/tv510834_4.xml","form_type":"4"}},{"id":3698400,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-11T02:14:23.000Z","date":"2019-01-08","kind":"exercise","acquired":true,"shares":2500,"price":11.83,"value":29575.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001144204-19-001393","document":"tv510834_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419001393/tv510834_4.xml","form_type":"4"}},{"id":3702260,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2019-01-08T01:08:36.000Z","date":"2019-01-07","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":9890,"derivative":{"exercise_price":11.83,"exercise_date":"2013-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001144204-19-000965","document":"tv510380_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419000965/tv510380_4.xml","form_type":"4"}},{"id":3702259,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2019-01-08T01:08:36.000Z","date":"2019-01-04","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":12390,"derivative":{"exercise_price":11.83,"exercise_date":"2013-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001144204-19-000965","document":"tv510380_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419000965/tv510380_4.xml","form_type":"4"}},{"id":3702258,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2019-01-08T01:08:36.000Z","date":"2019-01-03","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":14890,"derivative":{"exercise_price":11.83,"exercise_date":"2013-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001144204-19-000965","document":"tv510380_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419000965/tv510380_4.xml","form_type":"4"}},{"id":3702257,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-08T01:08:36.000Z","date":"2019-01-07","kind":"sale","acquired":false,"shares":2500,"price":32.21,"value":80525.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-19-000965","document":"tv510380_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419000965/tv510380_4.xml","form_type":"4"}},{"id":3702256,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-08T01:08:36.000Z","date":"2019-01-07","kind":"exercise","acquired":true,"shares":2500,"price":11.83,"value":29575.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001144204-19-000965","document":"tv510380_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419000965/tv510380_4.xml","form_type":"4"}},{"id":3702255,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-08T01:08:36.000Z","date":"2019-01-04","kind":"sale","acquired":false,"shares":2500,"price":31.3,"value":78250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-19-000965","document":"tv510380_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419000965/tv510380_4.xml","form_type":"4"}},{"id":3702254,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-08T01:08:36.000Z","date":"2019-01-04","kind":"exercise","acquired":true,"shares":2500,"price":11.83,"value":29575.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001144204-19-000965","document":"tv510380_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419000965/tv510380_4.xml","form_type":"4"}},{"id":3702253,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-08T01:08:36.000Z","date":"2019-01-03","kind":"sale","acquired":false,"shares":2500,"price":31.72,"value":79300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-19-000965","document":"tv510380_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419000965/tv510380_4.xml","form_type":"4"}},{"id":3702252,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2019-01-08T01:08:36.000Z","date":"2019-01-03","kind":"exercise","acquired":true,"shares":2500,"price":11.83,"value":29575.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001144204-19-000965","document":"tv510380_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420419000965/tv510380_4.xml","form_type":"4"}},{"id":3816128,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2018-09-15T01:04:11.000Z","date":"2018-09-12","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":17390,"derivative":{"exercise_price":11.83,"exercise_date":"2013-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001144204-18-049580","document":"tv502926_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418049580/tv502926_4.xml","form_type":"4"}},{"id":3816127,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2018-09-15T01:04:11.000Z","date":"2018-09-12","kind":"sale","acquired":false,"shares":2500,"price":44.3,"value":110750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-18-049580","document":"tv502926_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418049580/tv502926_4.xml","form_type":"4"}},{"id":3816126,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2018-09-15T01:04:11.000Z","date":"2018-09-12","kind":"exercise","acquired":true,"shares":2500,"price":11.83,"value":29575.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001144204-18-049580","document":"tv502926_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418049580/tv502926_4.xml","form_type":"4"}},{"id":4001515,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2018-03-13T01:11:22.000Z","date":"2018-03-12","kind":"exercise","acquired":false,"shares":13162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."}],"balance_after":0,"derivative":{"exercise_price":11.83,"exercise_date":"2012-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":13162},"source":{"system":"sec-edgar","filing":"0001144204-18-014217","document":"tv488170_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418014217/tv488170_4.xml","form_type":"4"}},{"id":4001514,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2018-03-13T01:11:22.000Z","date":"2018-03-09","kind":"exercise","acquired":false,"shares":6576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."}],"balance_after":13162,"derivative":{"exercise_price":11.83,"exercise_date":"2012-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":6576},"source":{"system":"sec-edgar","filing":"0001144204-18-014217","document":"tv488170_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418014217/tv488170_4.xml","form_type":"4"}},{"id":4001513,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2018-03-13T01:11:22.000Z","date":"2018-03-08","kind":"exercise","acquired":false,"shares":3425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."}],"balance_after":19738,"derivative":{"exercise_price":11.83,"exercise_date":"2012-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":3425},"source":{"system":"sec-edgar","filing":"0001144204-18-014217","document":"tv488170_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418014217/tv488170_4.xml","form_type":"4"}},{"id":4001512,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2018-03-13T01:11:22.000Z","date":"2018-03-12","kind":"sale","acquired":false,"shares":13162,"price":40,"value":526480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-18-014217","document":"tv488170_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418014217/tv488170_4.xml","form_type":"4"}},{"id":4001511,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2018-03-13T01:11:22.000Z","date":"2018-03-12","kind":"exercise","acquired":true,"shares":13162,"price":11.83,"value":155706.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."}],"balance_after":13162,"source":{"system":"sec-edgar","filing":"0001144204-18-014217","document":"tv488170_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418014217/tv488170_4.xml","form_type":"4"}},{"id":4001510,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2018-03-13T01:11:22.000Z","date":"2018-03-09","kind":"sale","acquired":false,"shares":6576,"price":40.03,"value":263237.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.10, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-18-014217","document":"tv488170_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418014217/tv488170_4.xml","form_type":"4"}},{"id":4001509,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2018-03-13T01:11:22.000Z","date":"2018-03-09","kind":"exercise","acquired":true,"shares":6576,"price":11.83,"value":77794.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."}],"balance_after":6576,"source":{"system":"sec-edgar","filing":"0001144204-18-014217","document":"tv488170_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418014217/tv488170_4.xml","form_type":"4"}},{"id":4001508,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2018-03-13T01:11:22.000Z","date":"2018-03-08","kind":"sale","acquired":false,"shares":3425,"price":40,"value":137000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-18-014217","document":"tv488170_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418014217/tv488170_4.xml","form_type":"4"}},{"id":4001507,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2018-03-13T01:11:22.000Z","date":"2018-03-08","kind":"exercise","acquired":true,"shares":3425,"price":11.83,"value":40517.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."}],"balance_after":3425,"source":{"system":"sec-edgar","filing":"0001144204-18-014217","document":"tv488170_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418014217/tv488170_4.xml","form_type":"4"}},{"id":4008789,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2018-03-08T02:47:06.000Z","date":"2018-03-06","kind":"exercise","acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."}],"balance_after":23163,"derivative":{"exercise_price":11.83,"exercise_date":"2012-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001144204-18-013456","document":"tv488031_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418013456/tv488031_4.xml","form_type":"4"}},{"id":4008788,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2018-03-08T02:47:06.000Z","date":"2018-03-05","kind":"exercise","acquired":false,"shares":3860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."}],"balance_after":23263,"derivative":{"exercise_price":11.83,"exercise_date":"2012-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":3860},"source":{"system":"sec-edgar","filing":"0001144204-18-013456","document":"tv488031_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418013456/tv488031_4.xml","form_type":"4"}},{"id":4008787,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2018-03-08T02:47:06.000Z","date":"2018-03-06","kind":"sale","acquired":false,"shares":100,"price":40.15,"value":4015.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-18-013456","document":"tv488031_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418013456/tv488031_4.xml","form_type":"4"}},{"id":4008786,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2018-03-08T02:47:06.000Z","date":"2018-03-06","kind":"exercise","acquired":true,"shares":100,"price":11.83,"value":1183.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001144204-18-013456","document":"tv488031_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418013456/tv488031_4.xml","form_type":"4"}},{"id":4008785,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2018-03-08T02:47:06.000Z","date":"2018-03-05","kind":"sale","acquired":false,"shares":3860,"price":40.06,"value":154631.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.15, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-18-013456","document":"tv488031_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418013456/tv488031_4.xml","form_type":"4"}},{"id":4008784,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2018-03-08T02:47:06.000Z","date":"2018-03-05","kind":"exercise","acquired":true,"shares":3860,"price":11.83,"value":45663.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."}],"balance_after":3860,"source":{"system":"sec-edgar","filing":"0001144204-18-013456","document":"tv488031_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418013456/tv488031_4.xml","form_type":"4"}},{"id":4228776,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2017-08-22T01:07:07.000Z","date":"2017-08-21","kind":"exercise","acquired":false,"shares":800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."}],"balance_after":27123,"derivative":{"exercise_price":11.83,"exercise_date":"2012-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":800},"source":{"system":"sec-edgar","filing":"0001144204-17-044479","document":"v473786_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417044479/v473786_form4.xml","form_type":"4"}},{"id":4228775,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2017-08-22T01:07:07.000Z","date":"2017-08-17","kind":"exercise","acquired":false,"shares":4176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."}],"balance_after":27923,"derivative":{"exercise_price":11.83,"exercise_date":"2012-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":4176},"source":{"system":"sec-edgar","filing":"0001144204-17-044479","document":"v473786_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417044479/v473786_form4.xml","form_type":"4"}},{"id":4228774,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2017-08-22T01:07:07.000Z","date":"2017-08-21","kind":"sale","acquired":false,"shares":800,"price":40.02,"value":32016.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.10, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-17-044479","document":"v473786_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417044479/v473786_form4.xml","form_type":"4"}},{"id":4228773,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2017-08-22T01:07:07.000Z","date":"2017-08-21","kind":"exercise","acquired":true,"shares":800,"price":11.83,"value":9464.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."}],"balance_after":800,"source":{"system":"sec-edgar","filing":"0001144204-17-044479","document":"v473786_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417044479/v473786_form4.xml","form_type":"4"}},{"id":4228772,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2017-08-22T01:07:07.000Z","date":"2017-08-17","kind":"sale","acquired":false,"shares":4176,"price":40.01,"value":167081.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.15, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-17-044479","document":"v473786_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417044479/v473786_form4.xml","form_type":"4"}},{"id":4228771,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2017-08-22T01:07:07.000Z","date":"2017-08-17","kind":"exercise","acquired":true,"shares":4176,"price":11.83,"value":49402.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."}],"balance_after":4176,"source":{"system":"sec-edgar","filing":"0001144204-17-044479","document":"v473786_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417044479/v473786_form4.xml","form_type":"4"}},{"id":4232838,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2017-08-17T01:07:05.000Z","date":"2017-08-16","kind":"exercise","acquired":false,"shares":5938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."}],"balance_after":32099,"derivative":{"exercise_price":11.83,"exercise_date":"2012-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":5938},"source":{"system":"sec-edgar","filing":"0001144204-17-043763","document":"v473493_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417043763/v473493_form4.xml","form_type":"4"}},{"id":4232837,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2017-08-17T01:07:05.000Z","date":"2017-08-15","kind":"exercise","acquired":false,"shares":1443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."}],"balance_after":38037,"derivative":{"exercise_price":11.83,"exercise_date":"2012-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":1443},"source":{"system":"sec-edgar","filing":"0001144204-17-043763","document":"v473493_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417043763/v473493_form4.xml","form_type":"4"}},{"id":4232836,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Option to purchase Common Stock","published_at":"2017-08-17T01:07:05.000Z","date":"2017-08-14","kind":"exercise","acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."}],"balance_after":39480,"derivative":{"exercise_price":11.83,"exercise_date":"2012-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0001144204-17-043763","document":"v473493_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417043763/v473493_form4.xml","form_type":"4"}},{"id":4232835,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2017-08-17T01:07:05.000Z","date":"2017-08-16","kind":"sale","acquired":false,"shares":5938,"price":40.04,"value":237757.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.13, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-17-043763","document":"v473493_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417043763/v473493_form4.xml","form_type":"4"}},{"id":4232834,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2017-08-17T01:07:05.000Z","date":"2017-08-16","kind":"exercise","acquired":true,"shares":5938,"price":11.83,"value":70246.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."}],"balance_after":5938,"source":{"system":"sec-edgar","filing":"0001144204-17-043763","document":"v473493_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417043763/v473493_form4.xml","form_type":"4"}},{"id":4232833,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2017-08-17T01:07:05.000Z","date":"2017-08-15","kind":"sale","acquired":false,"shares":1443,"price":40.05,"value":57792.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.15, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-17-043763","document":"v473493_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417043763/v473493_form4.xml","form_type":"4"}},{"id":4232832,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2017-08-17T01:07:05.000Z","date":"2017-08-15","kind":"exercise","acquired":true,"shares":1443,"price":11.83,"value":17070.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."}],"balance_after":1443,"source":{"system":"sec-edgar","filing":"0001144204-17-043763","document":"v473493_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417043763/v473493_form4.xml","form_type":"4"}},{"id":4232831,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2017-08-17T01:07:05.000Z","date":"2017-08-14","kind":"sale","acquired":false,"shares":300,"price":40.08,"value":12024.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.25, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-17-043763","document":"v473493_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417043763/v473493_form4.xml","form_type":"4"}},{"id":4232830,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Corporate Strategy"}}],"security":"Class A Common Stock","published_at":"2017-08-17T01:07:05.000Z","date":"2017-08-14","kind":"exercise","acquired":true,"shares":300,"price":11.83,"value":3549.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017."}],"balance_after":300,"source":{"system":"sec-edgar","filing":"0001144204-17-043763","document":"v473493_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417043763/v473493_form4.xml","form_type":"4"}}]}